Saturday, July 20, 2019
    Latest

    Dermatitis

    Home Dermatitis
    Dermatitis
    Dermatitis

    Edesa Biotech Receives Approval to Proceed from FDA for Phase 2B...

    0
    Penn State Study Reveals Hidradenitis Suppurativa Increases Alopecia Risk
    Dermatitis

    Penn State Study Reveals Hidradenitis Suppurativa Increases Alopecia Risk

    0
    Dermatitis

    New Regional Dermatoses Reported in Some Patients on Dupilumab

    4
    Dermatitis

    Colorado Team Raises Bar for Successful Management of Severe Atopic Dermatitis

    0
    Dermatitis

    University Hospitals Cleveland Research Develops Diagnostic Checklist for Generalized Dermatitis

    0
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    159 West Broadway Suite 200
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved